Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3 vs 10 Days of TMP-SMX for Skin Abscesses
NCT02024867Completed
- Start
- Feb 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trimethoprim + sulfamethoxazole in skin abscess (2 arms). Primary endpoints: Treatment Failures at 2 weeks, Treatment Failures Among Patients Infected With Methicillin-Resistant Staphylococcus Aureus at 2 weeks and 1 more. Started Feb 2010; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
skin abscess
Beyond the preview
Go deeper on NCT02024867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024867.